Regeneron

+$5.10 (+0.84%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Regeneron and other ETFs, options, and stocks.

About REGN

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP.

CEO
Leonard S. Schleifer
Employees
10,368
Headquarters
Tarrytown, New York
Founded
1988

REGN Key Statistics

Market cap
67.28B
Price-Earnings ratio
8.60
Dividend yield
—
Average volume
893.48K
High today
$613.15
Low today
$602.52
Open price
$611.54
Volume
817.84K
52 Week high
$747.42
52 Week low
$536.08

REGN News

Simply Wall StJun 23

Regeneron Pharmaceuticals' 24% CAGR outpaced the company's earnings growth over the same three-year period

It might be of some concern to shareholders to see the Regeneron Pharmaceuticals, Inc. ( ) share price down 14% in the last month. But don't let that distract f

REGN Earnings

$0.00
$8.60
$17.20
$25.80
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure